Citalopram infusion activated brain areas implicated in depression, including the subgenual cingulate gyrus, the amygdala, the caudate, and the ventral frontal cortex. Direct phfMRI using intravenous citalopram opens new ways of investigating 5-HT mechanisms in depression and its treatment. Here, HTR5A is linked to depressive symptom measurement.